Results 91 to 100 of about 13,127 (167)

Discovery of novel favipiravir derivatives with improved pharmacokinetic properties as anti-SFTSV agents

European Journal of Medicinal Chemistry Reports
Favipiravir is a nucleobase analogue that exhibits antiviral activities against a variety of RNA viruses. Due to the lack of antivirals to combat SFTS, an emerging tickborne epidemic caused by a RNA virus belonging to the Phenuividae family within ...
Xiaomeng He, Fan Wu, Wei Li, Runze Zhang, Ruiyang Sun, Zhihong Hu, Wu Zhong, Manli Wang   +7 more
doaj   +1 more source

Assessing favipiravir impact on SARS-CoV-2 transmission within households: Insights from a multi-center study (FaviPrev)

Journal of Virus Eradication
Background: While certain studies have demonstrated that antiviral treatment administered to index patients with influenza can mitigate the transmission within households, the efficacy of anti-SARS-CoV-2 agents in curtailing household transmission ...
Taweegrit Siripongboonsitti, Marisa Muadchimkaew, Kriangkrai Tawinprai, Ornisa Issaranon, Wichuda Meepholkij, Pureepat Arttawejkul, Apiradee Vararungzarit, Onwalee Dhissayakamol, Wilaiporn Preeyachit, Kamonwan Soonklang, Nithi Mahanonda   +10 more
doaj   +1 more source

Risk of Bias-Favipiravir for covid-19

Favipiravir for covid ...
pritish korula (17822568), Richard Kirubakaran (17822578), Hanna Alexander (17822569), Prathap Tharyan (17822581), Jisha Sara John (17822572), Bhagteshwar Singh (17822575), Priscilla Rupali (17807447)   +6 more
core   +1 more source

A RETROSPECTIVE ANALYSIS OF REPURPOSED THERAPEUTICS USED DURING THE DELTA VARIANT INDUCED COVID-19 CRISIS OF INDIA, 2021

Медицина в Кузбассе, 2023
COVID-19 has led to a major worldwide health and economic crisis, with more than 27 million people having contracted the disease and more than 800 000 deaths.
Srinivasa Jayachandra, Sadhana Sonti, Vijaya Vathsa, C.M.A. Beliappa, Praneetha Achanta   +4 more
doaj  

Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza.

, 2017
Favipiravir is a novel antiviral drug approved for influenza treatment in Japan. Little is known about favipiravir pharmacokinetics in critically ill patients.
Favié, Laurent Ma, Jean-Luc Murk, A Laura Nijstad, Maaike A Sikma, van Maarseveen, Erik M, Murk, Jean-Luc, Nijstad, A Laura, Sikma, Maaike A, Meijer, Adam, Adam Meijer, Laurent MA Favié, Erik M van Maarseveen   +11 more
core   +1 more source

AOP degradation of favipiravir

Voda je jedan od glavnih izvora života na našem planetu te njena kvaliteta direktno utječe na ljudsko zdravlje te biljni i životinjski svijet. Razvojem farmaceutske industrije prisutan je znatno veći broj novih onečišćujućih tvari kao što su farmaceutici
Mandir, Ivana
core  

The effect of favipiravir on fracture healing

Objective: The aim of this study was to evaluate the effects of favipiravir on fracture healing. Methods: Forty-eight female rats which had a femur fracture with intramedullary Kirschner wire fixation performed were divided into 6 groups; 2 control ...
Sabir, Mehmet Ali, Copuroglu, Cem, Celik, Ahmet Onur, Demirtas, Elif Mercan   +3 more
core   +1 more source

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

BMC Infectious Diseases
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral activity against SARS-CoV-2.
Viravarn Luvira, William H. K. Schilling, Podjanee Jittamala, James A. Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J. Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J. Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S. Aguiar, Franciele M. Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter R. J. Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P. J. Day, Mauro M. Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J. White, the PLATCOV Collaborative Group   +35 more
doaj   +1 more source

Cost-Effectiveness Analysis of Favipiravir and Remdesivir as COVID-19 Treatment in South Tangerang, Banten Province - Indonesia

Pharmacology and Clinical Pharmacy Research
COVID-19 is a contagious ailment primarily attributed to the severe acute respiratory syndrome coronavirus. Indonesia persists in confronting the COVID-19 pandemic, and South Tangerang City has emerged as one of the municipalities in Indonesia that has ...
Wahyu G. Putro, Andriani R. Fahriyati, Gilberto A. Julian, Tania R. Amalia, Zaki M. Riski   +4 more
doaj   +1 more source

Favipiravir Protects Enterocytes From Cell Death After Inflammatory Storm

Over the past years, inflammatory bowel disease (IBD) treatment has become more targeted, anticipating the use of immune-modifying therapies at an earlier stage.
Ensarioglu, HK, Celik, DA, Ozgurbuz, U, Vatansever, HS   +3 more
core